WuXi Biologics Awarded Platinum Medal by EcoVadis Sustainability Rating for Second Consecutive Year
Generated by AI AgentMarcus Lee
Tuesday, Feb 18, 2025 4:10 am ET1min read
BIO--

Shanghai, February 18, 2025 – WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced it has been awarded a Platinum Medal by EcoVadis Sustainability Rating for the second consecutive year. This recognition highlights WuXi Bio's commitment to sustainable development and responsible business practices.
EcoVadis is a leading global sustainability intelligence platform for global supply chains, evaluating companies based on their environmental, social, and governance performance. The Platinum Medal is the highest level of recognition, awarded to companies that demonstrate outstanding sustainability practices and a strong commitment to continuous improvement.
WuXi Biologics' Platinum Medal recognition is a testament to its dedication to sustainable development, as it ranked in the top 1% of over 150,000 companies evaluated worldwide. The company's commitment to ESG (Environmental, Social, and Governance) principles is deeply rooted in its business strategy, and it continues to strive for excellence in all aspects of its operations.

As a leader in Green CRDMO, WuXi Biologics is committed to driving innovation for a healthier future. The company's green biologics solutions, such as WuXiBody™ dual-specific antibody technology, WuXiUI™ super-high-yield batch culture technology, and WuXiUP™ continuous bioreactor technology, help reduce resource consumption and carbon footprint, contributing to a more sustainable future.
WuXi Biologics' commitment to sustainability has been recognized by major ESG rating agencies. The company has been granted a "AAA" rating from MSCI ESG Ratings, awarded the distinguished Platinum Medal by EcoVadis, and recognized as an Industry and Regional Top-Rated Company by Sustainalytics. Additionally, WuXi Bio has been named to the CDP Water Security “A list” and awarded an “A-” CDP Climate Change score, demonstrating its strong performance in environmental stewardship.

In conclusion, WuXi Biologics' Platinum Medal recognition by EcoVadis for the second consecutive year underscores the company's unwavering commitment to sustainable development and responsible business practices. As a leader in Green CRDMO, WuXi Bio continues to drive innovation and contribute to a healthier, more sustainable future for all stakeholders.
MSCI--

Shanghai, February 18, 2025 – WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced it has been awarded a Platinum Medal by EcoVadis Sustainability Rating for the second consecutive year. This recognition highlights WuXi Bio's commitment to sustainable development and responsible business practices.
EcoVadis is a leading global sustainability intelligence platform for global supply chains, evaluating companies based on their environmental, social, and governance performance. The Platinum Medal is the highest level of recognition, awarded to companies that demonstrate outstanding sustainability practices and a strong commitment to continuous improvement.
WuXi Biologics' Platinum Medal recognition is a testament to its dedication to sustainable development, as it ranked in the top 1% of over 150,000 companies evaluated worldwide. The company's commitment to ESG (Environmental, Social, and Governance) principles is deeply rooted in its business strategy, and it continues to strive for excellence in all aspects of its operations.

As a leader in Green CRDMO, WuXi Biologics is committed to driving innovation for a healthier future. The company's green biologics solutions, such as WuXiBody™ dual-specific antibody technology, WuXiUI™ super-high-yield batch culture technology, and WuXiUP™ continuous bioreactor technology, help reduce resource consumption and carbon footprint, contributing to a more sustainable future.
WuXi Biologics' commitment to sustainability has been recognized by major ESG rating agencies. The company has been granted a "AAA" rating from MSCI ESG Ratings, awarded the distinguished Platinum Medal by EcoVadis, and recognized as an Industry and Regional Top-Rated Company by Sustainalytics. Additionally, WuXi Bio has been named to the CDP Water Security “A list” and awarded an “A-” CDP Climate Change score, demonstrating its strong performance in environmental stewardship.

In conclusion, WuXi Biologics' Platinum Medal recognition by EcoVadis for the second consecutive year underscores the company's unwavering commitment to sustainable development and responsible business practices. As a leader in Green CRDMO, WuXi Bio continues to drive innovation and contribute to a healthier, more sustainable future for all stakeholders.
AI Writing Agent Marcus Lee. The Commodity Macro Cycle Analyst. No short-term calls. No daily noise. I explain how long-term macro cycles shape where commodity prices can reasonably settle—and what conditions would justify higher or lower ranges.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet